| Melanie Bahlo PhD | |
| Professor, Theme Leader (Healthy Development and Ageing) and Laboratory Head | |
| Nationality: | Australian/German |
| Workplaces: | WEHI, Parkville, VIC |
| Birth Place: | Germany |
| Education: | BSc Hons and PhD in population genetics from Monash University |
Professor Melanie Bahlo PhD is an Australian statistical geneticist and bioinformatician.
Bahlo's interest in science and biology developed at a very young age. Growing up in Germany, she used to record the birds that came and visited her bird feeder during winter.[1] Bahlo attended secondary school at Albury High School in Albury, Australia.[2] She received her PhD in population genetics from Monash University in 1997. Bahlo's research interests include statistics, genetics, bioinformatics, and population genetics. Her work has "led to the discovery of new genes involved in genetic diseases such as deafness and epilepsy".[3] She is a member of the team of scientists affiliated with the Lowy Medical Research Institute (LMRI) studying the genetic basis for macular telangiectasia type 2.[4] She directed the most recent Genome Wide Association Study (GWAS), which discovered common genetic variants associated with MacTel.
Professor Bahlo is Theme Leader and Laboratory Head at WEHI, where her groups work focusses on developing and applying state-of-the-art methods to understand complex genetic datasets to discover the genetic causes of human disorders such as epilepsy, ataxia, dementia, motor neuron disease, Parkinson’s disease, speech disorders and retinal disorders.[5]
The work of Bahlo and her team has recently focussed on brain and retinal disorders but previous work has included infectious organisms. Software developed by the Bahlo lab is freely available to other researchers. Bahlo has spoke publicaly about the challenges of data access in the genome research space, and the importance of repositories for genome data, especially for injecting global equity in genomic data sharing. [6]
Bahlo and colleagues (Mark Bennett and Haloom Rafehi) from WEHI (formally known as the Walter and Eliza Hall Institute of Medical Research) were members of an international consortium responsible for discovering two new gene mutations responsible for a rare type of epilepsy.[7]
Bahlo and colleagues also undertook pivotal work identifying five genetic risk locations in people who may be at risk of an inherited eye disease that can cause blindness, Macular Telangiectasia type 2. [8]